{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "c1665897-05e3-45e8-bbfe-745f154c03e6", "code": "N03AF01", "comments": "ATC|NERVOUS SYSTEM|ANTIEPILEPTICS|ANTIEPILEPTICS|Carboxamide derivatives|carbamazepine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N03AF01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "9ea24851-c558-4ea0-b19d-ace3eb5ceb7b", "code": "N0000175751", "comments": "Established Pharmacologic Class [EPC]|Mood Stabilizer [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175751", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "632ea33f-7024-486c-b77c-3f82d352c6da", "code": "N0000175753", "comments": "Established Pharmacologic Class [EPC]|Anti-epileptic Agent [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175753", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "3af636be-f0c3-45d0-8eff-633f3347ad0b", "code": "N0000008486", "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Electrical Activity Alteration [PE]|Disorganized Electrical Activity Alteration [PE]|Decreased Disorganized Electrical Activity [PE]|Decreased Central Nervous System Disorganized Electrical Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008486", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "c407b04a-1df4-4290-907e-d3e206667d9d", "code": "QN03AF01", "comments": "VATC|ANTIEPILEPTICS|ANTIEPILEPTICS|Carboxamide derivatives|carbamazepine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN03AF01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "2391383d-a5da-491c-b9a3-6b9727feca60", "code": "298-46-4", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=298-46-4", "code_system": "CAS", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a", "6a04a822-b206-4afa-803c-00c1438b2768" ] }, { "uuid": "dbdc4d74-6aff-481a-90d6-3279ad40aeaf", "code": "D002220", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68002220", "code_system": "MESH", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "c2d4fde0-7026-462d-b45e-e12c860cb78a", "code": "NBK548097", "comments": "LiverTox|CNS|Anticonvulsant|Aromatic anticonvulsant", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548097/", "code_system": "LIVERTOX", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "41420dde-2bad-40d2-851b-013fca2e320e", "code": "CARBAMAZEPINE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Carbamazepine", "code_system": "WIKIPEDIA", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "8142781e-716b-407b-8767-aed1c74a596e", "code": "24.2.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Medicines for mental and behavioural disorders|Medicines used in mood disorders|Medicines used in bipolar disorders", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/46/?section=152#type131", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "f4c7e9d7-e978-4bfd-af59-92de9e34cd1c", "code": "05", "comments": "WHO ESSENTIAL MEDICINES LIST|Anticonvulsants/antiepileptics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/46/?section=42#type128", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "0847c083-d10d-4a86-852f-c55afd30f5f3", "code": "SUB06113MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "cb1c6d76-5926-41a0-ac4c-927787980a02", "code": "1836", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=1836", "code_system": "INN", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "34ee6d61-da0e-4549-984b-0bec7db6c7ce", "code": "206-062-7", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.005.512", "code_system": "ECHA (EC/EINECS)", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "f9eb5bc9-106d-43b4-93fc-003c7e0f6908", "code": "5339", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5339", "code_system": "IUPHAR", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "dfc55249-999d-406e-9838-8d249db80a5f", "code": "CARBAMAZEPINE", "comments": "Description: A white to yellowish white, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water and ether R; soluble in ethanol (~750 g/l) TS. Category: Antiepileptic drug. Storage: Carbamazepine should be kept in a tightly closed container. Definition: Carbamazepine contains not less than 98.0% and not more than 102.0% of C15H12N2O, calculated with reference to the dried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.77.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "c4f5e838-2b96-4eeb-bf92-be574e88dbb3", "code": "2002", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/2002/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "c16d61f1-4174-409e-b7b9-a403870eafa7", "code": "m3053", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m3053?q=authorize", "code_system": "MERCK INDEX", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "c883b9d5-8c10-426b-86da-e5e3f2de45d1", "code": "DB00564", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00564", "code_system": "DRUG BANK", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "435f061b-289f-4013-a0a5-34acb9b231d7", "code": "CHEMBL108", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "code_system": "ChEMBL", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "50390927-975e-4651-91b8-e36e0de5201e", "code": "N0000191266", "comments": "Cytochrome P450 1A2 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000191266", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "fec8acac-fd08-47cb-98ab-95c68f53eac0", "code": "N0000185506", "comments": "Cytochrome P450 3A4 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000185506", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "e0728120-3417-4831-86c5-9c6c852a91df", "code": "N0000187064", "comments": "Cytochrome P450 2B6 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000187064", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "e5d3f786-56d8-456e-b9c8-9f3c35bd02d1", "code": "N0000185507", "comments": "Cytochrome P450 2C9 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000185507", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "d9beb8ca-0644-4b46-b85b-9102e617fff2", "code": "N0000185607", "comments": "Cytochrome P450 2C19 Inducers [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000185607", "code_system": "NDF-RT", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "bb2526e0-4c5d-4f6f-b4bc-3aafb453f893", "code": "2554", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/2554", "code_system": "PUBCHEM", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "d0e264d4-5f23-4849-8877-223facb94ee1", "code": "C341", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C341", "code_system": "NCI_THESAURUS", "references": [ "3bfc48a5-870c-4d5b-87f1-a99121395f4a" ] }, { "uuid": "266c762a-a421-5ed6-4e86-c0454380aa48", "code": "3019", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3019", "code_system": "HSDB", "references": [ "a66c6964-f294-c7d2-a15f-f848e53e9c3c" ] }, { "uuid": "10814cdb-db35-af8e-998d-95771e056be7", "code": "DTXSID4022731", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID4022731", "code_system": "EPA CompTox", "references": [ "302ba126-a484-ce95-189d-9307f9120261" ] }, { "uuid": "9efbc620-3045-e000-1611-e0cd66388638", "code": "43590", "comments": "ORPHAN DRUG|Designated/Withdrawn|For the emergency rescue treatment of status epilepticus, grand mal type.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=43590", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "b22380e9-09f3-ed22-4af1-171e6b4ebde2", "code": "265508", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of epilepsy patients who cannot take anything by mouth (NPO)", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=265508", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "00d432bc-8bc8-b726-9e21-c1f3dbbb7453", "code": "C264", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anticonvulsant Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C264", "code_system": "NCI_THESAURUS", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "f073fcb8-eda1-94da-38a3-3201e322d6a8", "code": "EU/3/16/1746", "comments": "EU ORPHAN DRUG|Positive|\"Treatment of metaphyseal chondrodysplasia, Schmid type\"", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161746", "code_system": "EU-Orphan Drug", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "4c8dc995-34af-42bd-810d-2b792f2277c5", "code": "33CM23913M", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "0d60aa0a-29e7-2bce-3809-3667ff400375", "code": "Carbamazepine", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM400/", "code_system": "LACTMED", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "c6d48923-9732-c9c5-9459-a2a4489c02b3", "code": "489", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/489", "code_system": "DRUG CENTRAL", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "e3a74468-d8d4-7a0a-a741-ea4e8a734874", "code": "3387", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:3387", "code_system": "CHEBI", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "ee3d206c-c598-9147-4e6d-704454dd7f2e", "code": "1093001", "type": "PRIMARY", "url": "https://store.usp.org/product/1093001", "code_system": "RS_ITEM_NUM", "references": [ "39fb958b-374b-1564-c209-bcae29a3758f" ] }, { "uuid": "91ed7ec6-9598-bfd8-708b-0cbf24ded7a3", "code": "100000092127", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "9965d73d-8875-a4a7-2852-90b75f4b2d86" ] }, { "uuid": "365105c2-1645-94c7-6d68-24e87543c76c", "code": "33CM23913M", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=33CM23913M", "code_system": "DAILYMED", "references": [ "f672a6bf-65ac-557f-ca8a-817134aec430" ] }, { "uuid": "0d9e2432-34f7-bdc4-5786-02473d7002ca", "code": "169864", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=169864", "code_system": "NSC", "references": [ "4e312738-bb46-e42e-6f05-4c5c46f05da1" ] } ], "substance_class": "chemical", "references": [ { "uuid": "7f6aeff0-4ff9-4805-8ee3-c1101421ec56", "citation": "Characterization of the Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass Spectrometry\nJ. L. Maggs, M. Pirmohamed, N. R. Kitteringham and B. K. Park\nDrug Metabolism and Disposition March 1997, 25 (3) 275-280;", "url": "http://dmd.aspetjournals.org/content/25/3/275", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d33c3067-5907-413a-b883-b6a4bed8996d", "citation": "Characterization of the Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass Spectrometry\nJ. L. Maggs, M. Pirmohamed, N. R. Kitteringham and B. K. Park\nDrug Metabolism and Disposition March 1997, 25 (3) 275-280;", "url": "http://dmd.aspetjournals.org/content/25/3/275", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "44ba45ac-898a-441b-9bf4-92b91eaf70ad", "citation": "Characterization of the Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass Spectrometry\nJ. L. Maggs, M. Pirmohamed, N. R. Kitteringham and B. K. Park\nDrug Metabolism and Disposition March 1997, 25 (3) 275-280;", "url": "http://dmd.aspetjournals.org/content/25/3/275", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "aa8c6263-7c1e-42c5-86b2-53b2deb5186b", "citation": "https://www.drugbank.ca/metabolites/DBMET00710", "doc_type": "DRUGBANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "040f70c8-65d9-47e0-9813-df0f8a4416b1", "citation": "Characterization of the Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass Spectrometry\nJ. L. Maggs, M. Pirmohamed, N. R. Kitteringham and B. K. Park\nDrug Metabolism and Disposition March 1997, 25 (3) 275-280;", "url": "http://dmd.aspetjournals.org/content/25/3/275", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "57f5ab0e-fba2-46a0-9033-8c778d41c0d6", "citation": "https://www.drugbank.ca/drugs/DB00564", "doc_type": "DRUGBANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "20c6ecc9-5385-48fc-86aa-b0086d38d0dc", "citation": "https://www.drugbank.ca/drugs/DB00564", "doc_type": "DRUGBANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6bb4271c-eb4c-4342-a175-e96d73f16b51", "citation": "https://www.drugbank.ca/drugs/DB00564", "doc_type": "DRUGBANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c67fa239-1b3d-4d18-a16e-24a8f68d7e32", "citation": "https://www.drugbank.ca/drugs/DB00564", "doc_type": "DRUGBANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "27d42bf0-ae8e-4087-9ce2-958cc8cd9c83", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "58d1250f-f419-487c-b3fc-f150f5a88c42", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "90358f46-e121-413e-8eca-d783ad69863f", "citation": "INN Proposed List 15", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL15.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d0c27ef0-b2d1-46e8-abba-af23fb127899", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "adaeece3-e7e8-4d68-a6e6-36a6334bee4c", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fc6a9e9e-1d10-4df5-aa05-b9d21916efb3", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "12e80ab4-7a10-44dd-a5e9-3da45fee86c8", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c90b9d01-8491-46b3-941b-064cb12fa87d", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "80b920a0-f108-4403-a7dc-50842ce892ee", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "178bb782-eea1-4e24-b4b6-d84fb6e8a84b", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a014c561-da71-44e4-84e8-862193655b48", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "bb58ae61-a647-4d87-8f99-9817bfc6fc65", "citation": "EMPIRICA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7c2d474b-5b51-4619-98e8-a03f63319113", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "91c0a079-baee-4ad2-8808-96de9a308191", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b91d6df3-b6aa-4d98-a71a-371fca53e3c5", "citation": "EP 7.8", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "973c051c-3472-4ff7-9ad5-5c0b31e2d106", "citation": "MERCK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e6fab67e-7bd4-4c9d-a6c6-b7a40311ca7c", "citation": "FDA_SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "59800e09-3ae1-4d0f-8949-78ef9a9f3255", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e87f8879-c5bf-4ac3-8c5b-bdda3b4dff81", "citation": "USP-MC", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "405cc53c-90f4-48bd-8b2e-e20c009db8d6", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "99bdf664-6a28-4846-9ec8-942b93caa29e", "citation": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd22916c-ee35-4b57-9b1b-68d106422f5d", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd22916c-ee35-4b57-9b1b-68d106422f5d", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3bfc48a5-870c-4d5b-87f1-a99121395f4a", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389663000, "tags": [ "NOMEN" ] }, { "uuid": "318b80d2-1986-4872-ad25-9764d534a236", "citation": "PHARMACOGENOMICS\\\\nJANUARY 2013, VOL. 14, NO. 1, PAGES 35-45 , DOI 10.2217/PGS.12.180", "url": "http://www.futuremedicine.com/doi/pdf/10.2217/pgs.12.180", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b468438c-1623-42ed-b6c3-7b11b3484c30", "citation": "BRADLEY M. KERR\\\\n; HUMAN LIVER CARBAMAZEPINE METABOLISM: ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION; BIOCHEMICAL PHARMACOLOGY;\\\\nVOLUME 47, ISSUE 11, 1 JUNE 1994, PAGES 1969?1979", "url": "http://www.sciencedirect.com/science/article/pii/000629529490071X#", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6ef34fbb-b85a-4af3-bce5-3a3c75ede6ae", "citation": "USP-MC", "url": "https://mc.usp.org/monographs/carbamazepine-0-2", "doc_type": "USP-MC", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "243c2e65-9986-471b-9746-e95678f726b5", "citation": "FRIGERIO.M;\\\\nFORMATION\\\\nOF STABLE\\\\nEPXIDES IN THE\\\\nKTABOLISM\\\\nOF TRIMCYCLIC\\\\nDRUGS;DRUG\\\\nMETABOLISM\\\\nREVIEWS.\\\\n5(2).\\\\n197-218\\\\n(1976)", "url": "http://informahealthcare.com/doi/pdf/10.3109/03602537609029978", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8f675d66-c830-44f5-bce8-0b83fc60d870", "citation": "SRS import [33CM23913M]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=33CM23913M", "doc_type": "SRS", "public_domain": true, "document_date": 1493389663000, "tags": [ "NOMEN" ] }, { "uuid": "50f53411-6147-4fd5-a09c-8f31f04713d8", "citation": "CARBAMAZEPINE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "351172b2-b725-4053-b2e3-6d15ad487e86", "citation": "CARBAMAZEPINE [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "aebfb40e-ac7b-4f73-b77e-efb78bbc61c3", "citation": "CARBAMAZEPINE [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "4d5e4c5e-e6c7-4851-9f48-7faa7a8781c3", "citation": "CARBAMAZEPINE [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "9a2c33eb-6ba8-4d58-aa15-c0bf70d85162", "citation": "CARBAMAZEPINE [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ea5999f6-911c-4d5b-a690-2e56301f725f", "citation": "CARBAMAZEPINE [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "eb207a71-4207-466b-8501-7c22cd0ecbb7", "citation": "CARBAMAZEPINE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "a11f90a3-ed24-4479-aee9-f6061f2463e9", "citation": "CARBAMAZEPINE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bbfe4466-6adc-40bd-9a79-57398973df1d", "citation": "CARBAMAZEPINE [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "0f52c957-5ae1-4cf5-8ad7-f5e5e20aef3c", "citation": "CARBAMAZEPINE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "2b2f58c2-334e-4cca-86f6-e7ca47bb02f8", "citation": "CARBAMAZEPINE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ca17cbc5-c9c3-4b59-8587-505a4e24af8e", "citation": "CARBAMAZEPINE [USP-RC]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "082879cb-d7be-44d1-9271-0660dc10f660", "citation": "CARBAMAZEPINE [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "514352a3-d9d8-636b-00d5-7e04d02882e0", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c9bb85ad-3c90-0b8b-e7ed-a078ea05db33", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "a66c6964-f294-c7d2-a15f-f848e53e9c3c", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+298-46-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d4f9b468-f0ec-931f-bd34-6e868b98d61f", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+298-46-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "302ba126-a484-ce95-189d-9307f9120261", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=298-46-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "44d31f4e-5e18-8614-cdf4-d1d22164decb", "citation": "http://fco.factsandcomparisons.com/lco/action/doc/retrieve/docid/fc_dfc/5549428#f_pharmacokinetics", "doc_type": "LEPINDEX", "public_domain": true }, { "uuid": "9965d73d-8875-a4a7-2852-90b75f4b2d86", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "3cd75cc9-dc55-5f90-5b6b-0afb336ee797", "citation": "USP/NF", "doc_type": "USPNF", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5fe1d094-c722-888e-ea40-997e3ad82c96", "citation": "EP", "doc_type": "EP", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4", "citation": "IP", "doc_type": "WHO INTERNATIONAL PHARMACOPOEIA", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "39fb958b-374b-1564-c209-bcae29a3758f", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "811ee921-5462-1675-ed66-c55fbfc628c1", "citation": "JAN", "doc_type": "JAN", "public_domain": true }, { "uuid": "7258a787-73b4-8548-4869-bb23b076bda7", "citation": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-003392-40/DE", "doc_type": "CLINICALTRIALS", "public_domain": true }, { "uuid": "6a04a822-b206-4afa-803c-00c1438b2768", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "24813ae4-b962-4989-941a-70f1f7d16a1f", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "25cd8ff8-480e-485b-affc-b7b1a9d08049", "citation": "J Chromatogr 154(2):272;1978", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "70a1489c-9c71-0314-5035-579746464c17", "citation": "USP-RS", "doc_type": "USPNF", "public_domain": true }, { "uuid": "1ee3c08b-d7e5-4a1e-8d33-b28da1cb3a18", "citation": "Baker, K. M., et al. \"Identification of a rearranged degradation product from carbamazepine-10, 11-epoxide.\" Journal of pharmaceutical sciences 62.3 (1973): 475-476.", "url": "https://www.sciencedirect.com/science/article/pii/S0022354915389152", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "89815d50-3d8d-cc54-027f-010601f8afe8", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "5363fb72-c495-e18f-d04a-fb832efa83e0", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "4e312738-bb46-e42e-6f05-4c5c46f05da1", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "7e642886-d0c7-8b6c-d384-0dfe53cd571c", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "f672a6bf-65ac-557f-ca8a-817134aec430", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "5dbb5d41-0ac0-4d07-afc7-6f58fe05ddc7", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "87e65d58-426b-4476-9e88-034c461c6a9a", "id": "87e65d58-426b-4476-9e88-034c461c6a9a", "molfile": "\n CDK 01142520512D\n\n 18 20 0 0 0 0 0 0 0 0999 V2000\n 27.7364 -6.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.3828 -8.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.8958 -8.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.7519 -7.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.1054 -6.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.5925 -5.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.1279 -4.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5681 -4.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.5906 -6.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.1035 -5.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.9596 -6.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.3132 -8.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.8002 -8.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9441 -7.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -8.2368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -9.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9972 -10.5765 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6988 -10.5765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 2 0 0 0 0\n 2 3 1 0 0 0 0\n 3 4 2 0 0 0 0\n 4 5 1 0 0 0 0\n 5 6 2 0 0 0 0\n 1 6 1 0 0 0 0\n 5 7 1 0 0 0 0\n 7 8 2 0 0 0 0\n 8 9 1 0 0 0 0\n 9 10 2 0 0 0 0\n 10 11 1 0 0 0 0\n 11 12 2 0 0 0 0\n 12 13 1 0 0 0 0\n 13 14 2 0 0 0 0\n 9 14 1 0 0 0 0\n 14 15 1 0 0 0 0\n 4 15 1 0 0 0 0\n 15 16 1 0 0 0 0\n 16 17 2 0 0 0 0\n 16 18 1 0 0 0 0\nM END", "smiles": "c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N", "formula": "C15H12N2O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "b8a257ed-7191-4648-9085-2ae8addc33cf" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "236.2691", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "f28abdb4-a572-44ec-ad2c-6d570f387681", "version": "85", "structure": { "id": "bf8c26e6-0ff8-49ea-8047-2bf56886dc78", "molfile": "\n JSDraw201142520512D\n\n 18 20 0 0 0 0 0 V2000\n 27.7364 -6.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.3828 -8.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.8958 -8.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.7519 -7.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.1054 -6.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.5925 -5.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.1279 -4.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.5681 -4.8155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.5906 -6.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.1035 -5.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 18.9596 -6.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 19.3132 -8.1536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 20.8002 -8.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9441 -7.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -8.2368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 23.3480 -9.7966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.9972 -10.5765 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 24.6988 -10.5765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 2 0 0 0 0\n 2 3 1 0 0 0 0\n 3 4 2 0 0 0 0\n 4 5 1 0 0 0 0\n 5 6 2 0 0 0 0\n 1 6 1 0 0 0 0\n 5 7 1 0 0 0 0\n 7 8 2 0 0 0 0\n 8 9 1 0 0 0 0\n 9 10 2 0 0 0 0\n 10 11 1 0 0 0 0\n 11 12 2 0 0 0 0\n 12 13 1 0 0 0 0\n 13 14 2 0 0 0 0\n 9 14 1 0 0 0 0\n 14 15 1 0 0 0 0\n 4 15 1 0 0 0 0\n 15 16 1 0 0 0 0\n 16 17 2 0 0 0 0\n 16 18 1 0 0 0 0\nM END", "smiles": "c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N", "formula": "C15H12N2O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "236.2691", "optical_activity": "NONE", "references": [ "8f675d66-c830-44f5-bce8-0b83fc60d870", "27d42bf0-ae8e-4087-9ce2-958cc8cd9c83", "90358f46-e121-413e-8eca-d783ad69863f" ], "stereo_centers": 0 }, "unii": "33CM23913M", "relationships": [ { "uuid": "ba5682b2-4a02-436e-afef-7a17bd243fe2", "amount": { "uuid": "84e1dfd8-065f-4568-b290-3f3516befb26" }, "type": "IMPURITY->PARENT", "references": [ "5fe1d094-c722-888e-ea40-997e3ad82c96", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4" ], "related_substance": { "uuid": "e4beeced-aaba-42ab-bc6b-5f8a158a1384", "refuuid": "5b9541ff-d0dc-4ea4-9fd1-ed174a240b3a", "name": "9-METHYLACRIDINE", "unii": "1F3Q4U9UIS", "linking_id": "1F3Q4U9UIS", "ref_pname": "9-METHYLACRIDINE", "substance_class": "reference" } }, { "uuid": "17d095b0-a33b-4967-ad99-2c562ee2e494", "amount": { "uuid": "a61a173c-17d9-451e-bf2f-238e2f428f1d" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "318b80d2-1986-4872-ad25-9764d534a236" ], "related_substance": { "uuid": "269cc616-da4c-42f4-9087-b9798683c5e2", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" } }, { "uuid": "ec697979-58e3-4fa5-8d0f-54dfaabdccc6", "amount": { "uuid": "fee2084f-681b-4e2b-bba2-8978751f0c0c" }, "type": "METABOLITE->PARENT", "references": [ "243c2e65-9986-471b-9746-e95678f726b5" ], "related_substance": { "uuid": "9575c051-7ddf-4960-9c79-9d12d9009278", "refuuid": "0dfe4fd1-47c9-4731-b786-747b184e339b", "name": "Dibenzazepine", "unii": "J411KQJ8C2", "linking_id": "J411KQJ8C2", "ref_pname": "Dibenzazepine", "substance_class": "reference" } }, { "uuid": "af289849-40b1-4e53-81d1-8b71c70e6505", "amount": { "uuid": "d33102bd-681d-44c8-a0a3-23657366b387" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "80f8bf9d-02d3-483a-91b0-8338b5c11bc8", "refuuid": "f28abdb4-a572-44ec-ad2c-6d570f387681", "name": "Carbamazepine", "unii": "33CM23913M", "linking_id": "33CM23913M", "ref_pname": "Carbamazepine", "substance_class": "reference" } }, { "uuid": "a9ce7ce0-3e77-488d-a812-88818fa4aaa4", "amount": { "uuid": "2a429847-08c4-40f9-87e2-489bc5d6188f" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "ceb49ae0-98a5-4d83-ac63-9714526363a8", "refuuid": "a111a1e7-bec6-4df5-9e07-d08944d9cfea", "name": "CARBAMAZEPINE DIHYDRATE", "unii": "78M1RMW7Q8", "linking_id": "78M1RMW7Q8", "ref_pname": "CARBAMAZEPINE DIHYDRATE", "substance_class": "reference" } }, { "uuid": "99dccf60-a1b9-443b-a5c8-f741f01c6ccb", "amount": { "uuid": "7e85a90d-0449-4502-a7b9-a406f2e2a4ee" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "318b80d2-1986-4872-ad25-9764d534a236" ], "related_substance": { "uuid": "54beb5c5-a2d7-438a-a552-2b8d121142cf", "refuuid": "dfc5c3ca-bf96-45b7-acc6-3034e22bc3ee", "name": "CYTOCHROME P450 2C8", "unii": "L0423Z5LDW", "linking_id": "L0423Z5LDW", "ref_pname": "CYTOCHROME P450 2C8", "substance_class": "reference" } }, { "uuid": "b2947bb7-4843-45e7-8a87-fbe57868dba3", "amount": { "uuid": "e796af57-7ec5-4b57-97ea-030e1e5c80b8" }, "type": "METABOLITE ACTIVE->PRODRUG", "mediator_substance": { "uuid": "f12e3aa0-4837-4caa-8ffe-f7623bf695ce", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" }, "references": [ "24813ae4-b962-4989-941a-70f1f7d16a1f", "25cd8ff8-480e-485b-affc-b7b1a9d08049" ], "related_substance": { "uuid": "7234e12f-0d39-4ed0-8a6d-3f9830d0c3c0", "refuuid": "55de82a7-a2e1-40fb-9e8d-9e68ed513a52", "name": "CARBAMAZEPINE-10,11-EPOXIDE", "unii": "QC9505F279", "linking_id": "QC9505F279", "ref_pname": "CARBAMAZEPINE-10,11-EPOXIDE", "substance_class": "reference" } }, { "uuid": "6a89e8d3-9055-49af-a5e7-6048375046cd", "amount": { "uuid": "29372122-458e-4ea6-b690-2d6e4b78e236" }, "type": "IMPURITY->PARENT", "references": [ "6ef34fbb-b85a-4af3-bce5-3a3c75ede6ae", "5fe1d094-c722-888e-ea40-997e3ad82c96", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4" ], "related_substance": { "uuid": "1194da0f-199c-431f-99af-a14a5ea12702", "refuuid": "db991ff7-3e0d-4651-8634-a4ffb09d91a9", "name": "(5H-DIBENZO(B,F)AZEPIN-5-YLCARBONYL)UREA", "unii": "0SF4XM6M0M", "linking_id": "0SF4XM6M0M", "ref_pname": "(5H-DIBENZO(B,F)AZEPIN-5-YLCARBONYL)UREA", "substance_class": "reference" } }, { "uuid": "cdba1d76-d4d6-41f1-b9e8-82580a47b66a", "amount": { "uuid": "c4e2790b-2b06-47c8-a378-61a8c72b986b" }, "type": "IMPURITY->PARENT", "references": [ "5fe1d094-c722-888e-ea40-997e3ad82c96", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4" ], "related_substance": { "uuid": "d8d1798e-b2d1-49cb-a6a6-735d2a93802d", "refuuid": "573d50a6-f6af-47f2-92b4-6786d37942d9", "name": "5-(Chlorocarbonyl)-5H-dibenz(b,f)azepine", "unii": "VUJ563PAI3", "linking_id": "VUJ563PAI3", "ref_pname": "5-(Chlorocarbonyl)-5H-dibenz(b,f)azepine", "substance_class": "reference" } }, { "uuid": "ee2e2c8f-e8e9-4eb5-a77a-0f1095a81f12", "amount": { "uuid": "3814a167-6c95-4503-bb28-3c109dccb481" }, "type": "IMPURITY->PARENT", "references": [ "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4", "5fe1d094-c722-888e-ea40-997e3ad82c96" ], "related_substance": { "uuid": "51400ef2-15cc-4c38-8cd7-fd5ee9ef4c43", "refuuid": "eb27f8a1-8232-4af1-a62c-0c43e5961421", "name": "10-BROMO-5H-DIBENZO(B,F)AZEPINE-5-CARBOXAMIDE", "unii": "6424369828", "linking_id": "6424369828", "ref_pname": "10-BROMO-5H-DIBENZO(B,F)AZEPINE-5-CARBOXAMIDE", "substance_class": "reference" } }, { "uuid": "0a934e45-a4da-4091-9209-0c3b705ee667", "amount": { "uuid": "314529b4-4bd0-46f6-b10f-61af8fbd387b" }, "type": "IMPURITY->PARENT", "references": [ "3cd75cc9-dc55-5f90-5b6b-0afb336ee797", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4", "5fe1d094-c722-888e-ea40-997e3ad82c96" ], "related_substance": { "uuid": "63ad53d5-7d41-4749-a33f-f20098f64a2a", "refuuid": "6b99b6ec-0460-4a76-856c-5241cd8ce1b1", "name": "DIHYDROCARBAMAZEPINE", "unii": "EC017VA9FR", "linking_id": "EC017VA9FR", "ref_pname": "DIHYDROCARBAMAZEPINE", "substance_class": "reference" } }, { "uuid": "7f8e3acf-e5d4-4a1d-9845-545493f0fb7c", "amount": { "uuid": "17aa3da3-1016-4496-b54e-8f207dd08cb9" }, "type": "IMPURITY->PARENT", "references": [ "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4", "5fe1d094-c722-888e-ea40-997e3ad82c96" ], "related_substance": { "uuid": "f94c7f62-0510-4386-a7d3-bf792bce0514", "refuuid": "0dfe4fd1-47c9-4731-b786-747b184e339b", "name": "Dibenzazepine", "unii": "J411KQJ8C2", "linking_id": "J411KQJ8C2", "ref_pname": "Dibenzazepine", "substance_class": "reference" } }, { "uuid": "4b9d7e7d-3985-48c0-ab4d-da89609945ff", "amount": { "uuid": "cbe51ff5-f6e5-4fbf-bcfb-43fddecfcf8c", "average": 86, "units": "%" }, "type": "BINDER->LIGAND", "references": [ "c9bb85ad-3c90-0b8b-e7ed-a078ea05db33" ], "related_substance": { "uuid": "daed977d-5369-4aa2-bbd7-7a2a54da8261", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "e4cda79e-de76-4fb3-bcc1-fbabf9b2a051", "amount": { "uuid": "fa2a2939-71b1-457a-819d-9325f506d3b2" }, "type": "TARGET->INHIBITOR", "related_substance": { "uuid": "b81707c9-5553-4425-999f-35dc5601d0c5", "refuuid": "3a91042b-6cb6-45fd-b405-160928106c14", "name": "SODIUM CHANNEL PROTEIN TYPE 5 SUBUNIT ALPHA", "unii": "F660L4205N", "linking_id": "F660L4205N", "ref_pname": "SODIUM CHANNEL PROTEIN TYPE 5 SUBUNIT ALPHA", "substance_class": "reference" } }, { "uuid": "936e71f5-5054-4bf1-b6cd-a496db01a0c4", "amount": { "uuid": "7e131a9d-82bc-4e3d-b18f-0f0828bf5606" }, "type": "IMPURITY->PARENT", "references": [ "5fe1d094-c722-888e-ea40-997e3ad82c96", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4" ], "related_substance": { "uuid": "f427add5-2163-43a6-a93b-8f66f21b7391", "refuuid": "32a78457-c549-45e9-9efb-e532dac5ba8c", "name": "Iminodibenzyl", "unii": "262BX7OE3U", "linking_id": "262BX7OE3U", "ref_pname": "Iminodibenzyl", "substance_class": "reference" } }, { "uuid": "db9b27ce-72a0-486e-805b-2733eb01dbeb", "amount": { "uuid": "246d5a10-0893-4065-8782-aa02b70cc9d6" }, "type": "METABOLITE->PARENT", "mediator_substance": { "uuid": "731f4343-a2e7-40df-b0ec-8dccd96c7af0", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" }, "references": [ "57f5ab0e-fba2-46a0-9033-8c778d41c0d6" ], "related_substance": { "uuid": "ae3c3ad3-84f5-46e0-a3b9-f4300cd50df9", "refuuid": "0f6cbe9c-536f-4bc7-ac88-d05a6ec86283", "name": "2,3-DIHYDROXYCARBAMAZEPINE", "unii": "B91J9LX3OM", "linking_id": "B91J9LX3OM", "ref_pname": "2,3-DIHYDROXYCARBAMAZEPINE" } }, { "uuid": "282e433c-2d4e-4561-8c8b-5c702ed039d6", "amount": { "uuid": "51517362-e629-4ebf-a8a6-24b0cb195b99" }, "type": "METABOLITE->PARENT", "references": [ "c67fa239-1b3d-4d18-a16e-24a8f68d7e32" ], "related_substance": { "uuid": "15c1a624-9d2e-4e2d-8df5-8ba9e0396a27", "refuuid": "f578ded9-f0d5-4c16-9625-d3f3b87022d9", "name": "HYDROXYCARBAMAZEPINE, 2-", "unii": "1UT0PR32AJ", "linking_id": "1UT0PR32AJ", "ref_pname": "HYDROXYCARBAMAZEPINE, 2-" } }, { "uuid": "b5dc2bb4-0461-4d5f-8c82-874c9264b23f", "amount": { "uuid": "464c0251-d29c-4229-8aea-90e6316d7582" }, "type": "METABOLITE->PARENT", "references": [ "20c6ecc9-5385-48fc-86aa-b0086d38d0dc" ], "related_substance": { "uuid": "6b5e2039-861c-46cd-84b3-06d14d261e78", "refuuid": "c1e37ff4-9632-470d-b1a3-f59674924a13", "name": "3H-BENZO(B)OXIRENO(2',3':4,5)BENZO(1,2-F)AZEPINE-3-CARBOXAMIDE", "unii": "ROH7C1VN86", "linking_id": "ROH7C1VN86", "ref_pname": "3H-BENZO(B)OXIRENO(2',3':4,5)BENZO(1,2-F)AZEPINE-3-CARBOXAMIDE" } }, { "uuid": "7374071c-1455-4c13-82a3-13b157e4fff9", "amount": { "uuid": "04ea9e29-c05b-4819-9bbb-62c04b6ed6be" }, "type": "METABOLITE->PARENT", "mediator_substance": { "uuid": "1a62b89b-1f39-4e9e-aaf6-4a74fd04ce41", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" }, "references": [ "6bb4271c-eb4c-4342-a175-e96d73f16b51" ], "related_substance": { "uuid": "e046736a-a31e-4fd1-9158-879d48988ad8", "refuuid": "71ea88eb-1f1c-4a7f-aab6-1c5157a316c6", "name": "2-HYDROXYIMINOSTILBENE", "unii": "K78KH13GVF", "linking_id": "K78KH13GVF", "ref_pname": "2-HYDROXYIMINOSTILBENE" } }, { "uuid": "8129a5e6-8259-4577-aad8-e247cfe629dc", "amount": { "uuid": "af8a8cc9-e59b-4014-b7f8-53cc9a1f17b9" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "44ba45ac-898a-441b-9bf4-92b91eaf70ad" ], "related_substance": { "uuid": "4bccb0b7-38d2-450b-93ef-9d9c44d7a7d9", "refuuid": "f255e3da-67c7-49a3-be07-00a24698c2bd", "name": "1-DEOXY-1-((5H-DIBENZ(B,F)AZEPIN-5-YLCARBONYL)AMINO)-.BETA.-D-GLUCOPYRANURONIC ACID", "unii": "FRX2CL2J2P", "linking_id": "FRX2CL2J2P", "ref_pname": "1-DEOXY-1-((5H-DIBENZ(B,F)AZEPIN-5-YLCARBONYL)AMINO)-.BETA.-D-GLUCOPYRANURONIC ACID" } }, { "uuid": "9508d6d3-16f9-4914-ba99-3d8c210570f4", "amount": { "uuid": "0aa0c4e9-3839-480e-8c4f-725739a64a15" }, "type": "METABOLITE->PARENT", "mediator_substance": { "uuid": "a56ec1bb-43a2-4d44-b4b4-3b431b675fee", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" }, "references": [ "aa8c6263-7c1e-42c5-86b2-53b2deb5186b" ], "related_substance": { "uuid": "a5176077-5bab-4ef1-913b-64399703ca72", "refuuid": "c9745cc0-d705-41e4-8a8d-01af58b6e659", "name": "3-HYDROXYCARBAMAZEPINE", "unii": "PDG5O25MKO", "linking_id": "PDG5O25MKO", "ref_pname": "3-HYDROXYCARBAMAZEPINE" } }, { "uuid": "b6ef7eb7-136e-461c-b354-c1ef85374990", "amount": { "uuid": "a49b01a4-8e98-4f87-a662-f303a683ad80" }, "qualification": "URINE", "type": "IMPURITY->PARENT", "interaction_type": "MINOR", "references": [ "040f70c8-65d9-47e0-9813-df0f8a4416b1" ], "related_substance": { "uuid": "6b47e2dc-6472-412a-9b8a-1496aea89cb2", "refuuid": "8553fb4d-11ba-439b-aed2-d65bdcdffe67", "name": "MYTHYLSULFONYLCARBAMAZEPINE", "unii": "8VE3ZG5JUH", "linking_id": "8VE3ZG5JUH", "ref_pname": "MYTHYLSULFONYLCARBAMAZEPINE" } }, { "uuid": "286a405b-ba5a-45b4-86ae-84a0fd63c50f", "amount": { "uuid": "4bdeda84-9edc-449f-bacf-433477069502" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "d33c3067-5907-413a-b883-b6a4bed8996d" ], "related_substance": { "uuid": "bf92536f-1889-4ae9-adc9-9f7d5e7f2cf0", "refuuid": "e6a833bd-26dc-4318-b401-45c66b68a100", "name": ".BETA.-D-GLUCOPYRANOSIDURONIC ACID, 5-(AMINOCARBONYL)-10,11-DIHYDRO-11-HYDROXY-5H-DIBENZ(B,F)AZEPIN-10-YL", "unii": "XNH9NA6S49", "linking_id": "XNH9NA6S49", "ref_pname": ".BETA.-D-GLUCOPYRANOSIDURONIC ACID, 5-(AMINOCARBONYL)-10,11-DIHYDRO-11-HYDROXY-5H-DIBENZ(B,F)AZEPIN-10-YL" } }, { "uuid": "4948f5d7-5369-4370-aef4-2207c7a9281f", "amount": { "uuid": "37f67a7c-12fe-4be9-a39d-125af415ae36" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "7f6aeff0-4ff9-4805-8ee3-c1101421ec56" ], "related_substance": { "uuid": "284f40d4-fb11-4b1c-8411-62bfa3ceecaa", "refuuid": "f1b8f911-6ae6-4dc6-b2ed-41f53be5c906", "name": ".BETA.-D-GLUCOPYRANOSIDURONIC ACID, (10-(AMINOCARBONYL)-9,10-DIHYDRO-9-METHYL-9-ACRIDINYL)METHYL", "unii": "AG6XQN7VRZ", "linking_id": "AG6XQN7VRZ", "ref_pname": ".BETA.-D-GLUCOPYRANOSIDURONIC ACID, (10-(AMINOCARBONYL)-9,10-DIHYDRO-9-METHYL-9-ACRIDINYL)METHYL" } }, { "uuid": "11b98728-bc23-fc20-13cd-938eacdad811", "amount": { "uuid": "fc3b9455-d1ce-4062-a809-8f6209275122" }, "type": "SOLVATE->ANHYDROUS", "references": [ "6a04a822-b206-4afa-803c-00c1438b2768" ], "related_substance": { "uuid": "09e8917d-ac66-4caa-b995-fa271e01f3f5", "refuuid": "a111a1e7-bec6-4df5-9e07-d08944d9cfea", "name": "CARBAMAZEPINE DIHYDRATE", "unii": "78M1RMW7Q8", "linking_id": "78M1RMW7Q8", "ref_pname": "CARBAMAZEPINE DIHYDRATE" } }, { "uuid": "66998d8e-0351-470d-b808-20cc826680ce", "amount": { "uuid": "f09508ae-95a8-4fdf-8abc-82e20f659cf6" }, "type": "IMPURITY->PARENT", "related_substance": { "uuid": "9ab669d4-3a4e-4a88-ab37-d3c72b5f5a08", "refuuid": "d7e86f07-1622-4eb5-917b-79e8a7196857", "name": "N-ACETYL CARBAMAZEPINE", "unii": "2F6Q7L747N", "linking_id": "2F6Q7L747N", "ref_pname": "N-ACETYL CARBAMAZEPINE" } }, { "uuid": "e1946c22-b607-4d6b-9f39-a691c9424ff5", "amount": { "uuid": "4679cffd-89c5-49b6-a747-22e52b273eaa" }, "type": "METABOLITE->PARENT", "references": [ "1ee3c08b-d7e5-4a1e-8d33-b28da1cb3a18" ], "related_substance": { "uuid": "c6d3c47e-8fb3-484d-b62e-93375e0d5171", "refuuid": "f986642a-a0cf-4183-8d42-032f2e7696d4", "name": "9-ACRIDINECARBOXALDEHYDE", "unii": "5XN5ZGH695", "linking_id": "5XN5ZGH695", "ref_pname": "9-ACRIDINECARBOXALDEHYDE" } }, { "uuid": "41ccf49e-42d6-49f8-8369-89847c5c437e", "amount": { "uuid": "2ed09c62-5b08-4200-9bf0-c1f28711d17e" }, "type": "TARGET->INHIBITOR", "related_substance": { "uuid": "8a72d166-56db-4cd9-8868-2ddc622ecdf4", "refuuid": "7ce8de6e-75b5-474a-ba0c-8e96fc932a03", "name": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA", "unii": "PIV978KC1N", "linking_id": "PIV978KC1N", "ref_pname": "SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA", "substance_class": "reference" } } ], "names": [ { "uuid": "46bd7038-aac8-47c7-b212-a8596e15e751", "name": "5H-DIBENZ(B,F)AZEPINE-5-CARBOXAMIDE", "stdName": "5H-DIBENZ(B,F)AZEPINE-5-CARBOXAMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "bc60677b-aa30-4aa8-8d5f-608e8116403e", "name": "BISTON", "stdName": "BISTON", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "d5f4dc50-076d-468e-a3bc-b618d445ce14", "name": "CARBAMAZEPINE ANHYDROUS", "stdName": "CARBAMAZEPINE ANHYDROUS", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e6fab67e-7bd4-4c9d-a6c6-b7a40311ca7c" ], "display_name": false }, { "uuid": "bbda9ee7-8e2e-4763-aa0c-9864fe4deb6a", "name": "CARBAMAZEPINE EXTENDED RELEASE", "stdName": "CARBAMAZEPINE EXTENDED RELEASE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "bb58ae61-a647-4d87-8f99-9817bfc6fc65" ], "display_name": false }, { "uuid": "9d89232d-46ca-5c0e-6265-f362af8c9225", "name": "CARBAMAZEPINE [EP MONOGRAPH]", "stdName": "CARBAMAZEPINE [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5363fb72-c495-e18f-d04a-fb832efa83e0" ], "display_name": false }, { "uuid": "d2f5b297-b0a8-45c5-8bf1-b05bdc82cd84", "name": "CARBAMAZEPINE [HSDB]", "stdName": "CARBAMAZEPINE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "178bb782-eea1-4e24-b4b6-d84fb6e8a84b" ], "display_name": false }, { "uuid": "66a8ffb1-9bd1-8646-3cae-453439b77a4a", "name": "CARBAMAZEPINE [JAN]", "stdName": "CARBAMAZEPINE [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "811ee921-5462-1675-ed66-c55fbfc628c1" ], "display_name": false }, { "uuid": "ad740a18-dc06-4ea9-beed-67ece21b724f", "name": "CARBAMAZEPINE [MART.]", "stdName": "CARBAMAZEPINE [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c90b9d01-8491-46b3-941b-064cb12fa87d" ], "display_name": false }, { "uuid": "d13d619a-1ab5-4df1-b01c-18e2db5e49fe", "name": "CARBAMAZEPINE [MI]", "stdName": "CARBAMAZEPINE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "80b920a0-f108-4403-a7dc-50842ce892ee" ], "display_name": false }, { "uuid": "7b376d96-a6a1-43a3-b449-12dea20afc79", "name": "CARBAMAZEPINE [ORANGE BOOK]", "stdName": "CARBAMAZEPINE [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "12e80ab4-7a10-44dd-a5e9-3da45fee86c8" ], "display_name": false }, { "uuid": "a8722c9c-ee59-46fb-8dc9-ab5b2590a22d", "name": "CARBAMAZEPINE [USAN]", "stdName": "CARBAMAZEPINE [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d0c27ef0-b2d1-46e8-abba-af23fb127899" ], "display_name": false }, { "uuid": "c0f0c68d-cd0a-d1c5-9de6-8534ea59d719", "name": "CARBAMAZEPINE [USP IMPURITY]", "stdName": "CARBAMAZEPINE [USP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "fc6a9e9e-1d10-4df5-aa05-b9d21916efb3" ], "display_name": false }, { "uuid": "dfd354bc-b9a3-4ffb-be9c-b94ca889c194", "name": "CARBAMAZEPINE [USP MONOGRAPH]", "stdName": "CARBAMAZEPINE [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "89815d50-3d8d-cc54-027f-010601f8afe8" ], "display_name": false }, { "uuid": "dc8b6074-e705-4253-941a-2b9905ca467c", "name": "CARBAMAZEPINE [USP-RS]", "stdName": "CARBAMAZEPINE [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a014c561-da71-44e4-84e8-862193655b48" ], "display_name": false }, { "uuid": "642e62be-72e3-4f4d-ba3e-824b4d8d489b", "name": "CARBAMAZEPINE [VANDF]", "stdName": "CARBAMAZEPINE [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "91c0a079-baee-4ad2-8808-96de9a308191" ], "display_name": false }, { "uuid": "517a5d7c-f5e9-448d-a9d2-946e8eac0efd", "name": "CARBAMAZEPINE [WHO-IP]", "stdName": "CARBAMAZEPINE [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "405cc53c-90f4-48bd-8b2e-e20c009db8d6", "eb469191-ebf6-cd8e-251f-39d2a8fe0ba4" ], "display_name": false }, { "uuid": "e106e7d2-d687-42f4-a6b5-28d817049b4a", "name": "CARBAMAZEPINUM [WHO-IP LATIN]", "stdName": "CARBAMAZEPINUM [WHO-IP LATIN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "405cc53c-90f4-48bd-8b2e-e20c009db8d6" ], "display_name": false }, { "uuid": "d2c04b7d-4328-4564-b541-a2fd7ed34e2b", "name": "CARBATROL", "stdName": "CARBATROL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "f3bcde44-ea12-46ae-9ac8-42e85b471bac", "name": "CARNEXIV", "stdName": "CARNEXIV", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "99bdf664-6a28-4846-9ec8-942b93caa29e" ], "display_name": false }, { "uuid": "daf2217a-c70b-44d0-8f5a-c7023f38ac31", "name": "Carbamazepine", "stdName": "CARBAMAZEPINE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "50f53411-6147-4fd5-a09c-8f31f04713d8", "ea5999f6-911c-4d5b-a690-2e56301f725f", "90358f46-e121-413e-8eca-d783ad69863f", "e87f8879-c5bf-4ac3-8c5b-bdda3b4dff81", "12e80ab4-7a10-44dd-a5e9-3da45fee86c8", "082879cb-d7be-44d1-9271-0660dc10f660", "eb207a71-4207-466b-8501-7c22cd0ecbb7", "0f52c957-5ae1-4cf5-8ad7-f5e5e20aef3c", "405cc53c-90f4-48bd-8b2e-e20c009db8d6", "9a2c33eb-6ba8-4d58-aa15-c0bf70d85162", "80b920a0-f108-4403-a7dc-50842ce892ee", "91c0a079-baee-4ad2-8808-96de9a308191", "aebfb40e-ac7b-4f73-b77e-efb78bbc61c3", "bbfe4466-6adc-40bd-9a79-57398973df1d", "adaeece3-e7e8-4d68-a6e6-36a6334bee4c", "d0c27ef0-b2d1-46e8-abba-af23fb127899", "c90b9d01-8491-46b3-941b-064cb12fa87d", "a014c561-da71-44e4-84e8-862193655b48", "7c2d474b-5b51-4619-98e8-a03f63319113", "178bb782-eea1-4e24-b4b6-d84fb6e8a84b", "ca17cbc5-c9c3-4b59-8587-505a4e24af8e", "4d5e4c5e-e6c7-4851-9f48-7faa7a8781c3", "a11f90a3-ed24-4479-aee9-f6061f2463e9", "351172b2-b725-4053-b2e3-6d15ad487e86", "27d42bf0-ae8e-4087-9ce2-958cc8cd9c83", "fc6a9e9e-1d10-4df5-aa05-b9d21916efb3", "2b2f58c2-334e-4cca-86f6-e7ca47bb02f8" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "b4747503-2416-4431-bde9-56e09133239c", "name_org": "INN" }, { "uuid": "13cd6146-5861-44f1-aa83-f85cf55dfd16", "name_org": "USAN" } ] }, { "uuid": "a14737b4-1f1e-e4f2-128c-0fe2ed56ac32", "name": "Carbamazepine [WHO-DD]", "stdName": "CARBAMAZEPINE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7e642886-d0c7-8b6c-d384-0dfe53cd571c" ], "display_name": false }, { "uuid": "950b4c94-5444-4e27-9b1b-f098c65b741f", "name": "EPITOL", "stdName": "EPITOL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "129dc021-3519-445a-b1da-e0bd758718c2", "name": "EQUETRO", "stdName": "EQUETRO", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "77e8f79f-2a2a-480d-ab41-09ecde1720e8", "name": "FINLEPSIN", "stdName": "FINLEPSIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "39c478a7-75ae-44aa-aaeb-3d2b9fdf242f", "name": "G-32883", "stdName": "G-32883", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "d0879b98-d9d5-4868-b714-5281787c3fd5", "name": "GEIGY 32883", "stdName": "GEIGY 32883", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "1a345588-c605-45a6-8115-0e930cc4a4c9", "name": "KARBAMAZEPIN", "stdName": "KARBAMAZEPIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "d74e34b7-5a94-4b94-8259-cf8e974a844b", "name": "KARBELEX", "stdName": "KARBELEX", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "5afc617c-cb65-4e4a-abe3-d8456dcf1d36", "name": "NEUROTOL", "stdName": "NEUROTOL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "198144e5-3176-4ffb-b5a8-75b0c0423e0e", "name": "NEUROTOP", "stdName": "NEUROTOP", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "72293b45-cb8b-4b43-a54e-9160f37805b4", "name": "NSC-169864", "stdName": "NSC-169864", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "59800e09-3ae1-4d0f-8949-78ef9a9f3255" ], "display_name": false }, { "uuid": "d6aa9369-6d64-951a-88c3-f560d2dfff9e", "name": "OXCARBAZEPINE IMPURITY A [EP IMPURITY]", "stdName": "OXCARBAZEPINE IMPURITY A [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b91d6df3-b6aa-4d98-a71a-371fca53e3c5" ], "display_name": false }, { "uuid": "7640b328-72ee-4faf-8d89-06ce2fb8ecc4", "name": "SIRTAL", "stdName": "SIRTAL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "a0b39cc4-573b-4ee8-9c76-34986d8c53fd", "name": "STAZEPINE", "stdName": "STAZEPINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "d8fbf367-38ad-c8c7-339f-c5e3473471d3", "name": "TEGRETAL", "stdName": "TEGRETAL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "7258a787-73b4-8548-4869-bb23b076bda7" ], "display_name": false }, { "uuid": "56a4d448-c6f2-49d1-b4ff-4a567047878a", "name": "TEGRETOL", "stdName": "TEGRETOL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "c0b19778-5e28-4d3b-b2cd-d17b42231a4a", "name": "TELESMIN", "stdName": "TELESMIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "18d80c92-e874-41cf-b417-b6daa69711ba", "name": "TERIL", "stdName": "TERIL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "58d1250f-f419-487c-b3fc-f150f5a88c42" ], "display_name": false }, { "uuid": "d4d8f743-6f47-4fae-816d-a816d4c75725", "name": "TIMONIL", "stdName": "TIMONIL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "973c051c-3472-4ff7-9ad5-5c0b31e2d106" ], "display_name": false }, { "uuid": "1c86fad0-0461-4548-b995-841b14436338", "name": "carbamazepine [INN]", "stdName": "CARBAMAZEPINE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "90358f46-e121-413e-8eca-d783ad69863f" ], "display_name": false } ], "properties": [ { "uuid": "4d76c659-1692-4ef4-a1e3-f44f0b9ca933", "name": "Biological Half-life", "value": { "uuid": "a824dfd4-5cda-44c9-a20c-b553434d73c5", "high": 17, "low": 12, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "44d31f4e-5e18-8614-cdf4-d1d22164decb" ] }, { "uuid": "057103fa-9a1e-4dc2-ace8-1418c00c2a46", "name": "Volume of Distribution", "value": { "uuid": "7dc08c54-3c90-4531-9185-1f07a93bfefd", "high": 2, "low": 0.59, "units": "Liters/Kilogram" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "44d31f4e-5e18-8614-cdf4-d1d22164decb" ] } ] } ] }